NEW YORK, Sept. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of PubMatic, Inc. (NASDAQ: PUBM) between February 27, 2025 and August 11, 2025, both dates inclusive (the “Class Period”), of the important October 20, 2025 lead plaintiff deadline. SO WHAT: If you purchased PubMatic securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. ...

NEW YORK, Sept. 13, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Snap Inc. (NYSE: SNAP) between April 29, 2025 and August 5, 2025, both dates inclusive (the “Class Period”), both dates inclusive, of the important October 20, 2025 lead plaintiff deadline. SO WHAT: If you purchased Snap securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arran ...

NEW YORK, Sept. 12, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Sable Offshore Corp. (NYSE: SOC): (1) between May 19, 2025 and June 3, 2025, both dates inclusive (the “Class Period”); and/or (2) pursuant and/or traceable to Sable’s May 21, 2025 secondary public offering (the “SPO”), of the important September 26, 2025 lead plaintiff deadline in the securities class action first filed by the Firm. SO WHAT: If you purchased Sable securi ...

集体诉讼案件细节 - 诉讼指控SelectQuote在2020年9月9日至2025年5月1日期间向投资者发布虚假和误导性声明[1][4] - 公司被指控将医疗保险受益人引导至提供最高补偿的保险公司计划 而非基于计划质量或适用性[4] - 公司未提供公正的Medicare Advantage保险计划比价服务 并涉嫌收受非法回扣以限制竞争对手计划 enrollment[4] - 这些行为导致公司违反相关法律法规和合同条款 包括可能违反《虚假申报法》[4] - 当市场获悉真实情况后 投资者遭受财务损失[4] 法律程序时间节点 - 首席原告申请截止日期为2025年10月10日[1][2] - 投资者可通过指定网站或电话联系Phillip Kim律师参与集体诉讼[2][5] - 在集体认证完成前 投资者需自行保留法律代表或选择不作为缺席集体成员[6] 律师事务所背景 - Rosen Law Firm专注于证券集体诉讼和股东派生诉讼 2017年获得ISS证券集体诉讼服务数量排名第一[3] - 该律所2019年为投资者追回超过4.38亿美元资金 2020年创始合伙人被Law360评为原告律师界泰斗[3] - 律所在2013年以来每年保持前四排名 累计为投资者追回数亿美元资金[3]

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In Lantheus To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in Lantheus between February 26, 2025 and August 5, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, Sept. 11, 2025 (GLO ...

Sep 11, 2025 1:00 PM Eastern Daylight Time Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm, on Twitter: https://twitter.com/rosen_firm or on Facebook: https://www.facebook.com/rosenlawfirm/. Rosen Law Firm Urges Unicycive Therapeutics, Inc. (NASDAQ: UNCY) Stockholders with Large Losses to Contact the Firm for Information About Their Rights Share NEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces that a shareholder filed a class acti ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fiserv, Inc. (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline. SO WHAT: If you purchased Fiserv common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO ...

Accessibility StatementSkip Navigation Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Lockheed Martin To Contact Him Directly To Discuss Their Options If you purchased or acquired securities in Lockheed Martin between January 23, 2024 and July 21, 2025and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247- 4292 or 212-983-9330Â (Ext. 1310). [You may also click here for additional informatio ...

法律调查与指控 - 律师事务所Faruqi & Faruqi正在调查Nutex Health Inc（纳斯达克：NUTX）的潜在证券法违规行为 并提醒投资者在2025年10月21日前申请成为集体诉讼的首席原告[3] - 指控称公司及其高管通过做出虚假和/或误导性陈述及/或未能披露信息而违反联邦证券法 具体包括HaloMD通过协调欺诈计划从保险公司获取利润以及公司财务报告内部控制存在重大弱点[5] - 指控内容还包括公司夸大其业务和/或财务前景 导致被告的公开陈述在所有相关时间均存在重大虚假和误导性[5] 做空报告与市场反应 - 2025年7月22日 Blue Orca Capital发布针对Nutex的做空报告 指控公司因与第三方供应商HaloMD的关系而面临诉讼风险 HaloMD近期因参与“协调欺诈计划”代表医疗账单客户从保险公司获取数百万美元而被起诉[6] - 做空报告发布后 Nutex股价下跌11.18美元（跌幅10.05%）至100.01美元[7] - 2025年8月15日 因公司未能反驳做空报告指控 Nutex股价进一步下跌18.22美元（跌幅16.39%）至92.91美元[8] 公司回应与财务报告延迟 - 2025年7月24日 Nutex发布新闻稿回应做空报告 表示“强烈不同意报告中的指控”并预计“在2025年8月14日或之前提交的2025年第二季度10-Q表格和即将发布的盈利报告中提供相关更新”[7] - 2025年8月14日市场收盘后 Nutex宣布“延迟提交截至2025年6月30日的10-Q表格” 理由是与“某些在建和扩建医院的股票薪酬义务处理相关的非现金会计调整”[7][8]

公司财务与运营状况 - 公司股息可持续性低于管理层向投资者传达的水平 股息无法通过经营现金流完全覆盖 自2021年转为REIT以来一直存在资金缺口[5] - 公司采用不可持续的操纵性做法虚增AFFO 在计算AFFO时排除了同业均计入的经常性资本支出 从而夸大Ashford Lane物业的真实盈利能力[5][6] - 公司通过股份稀释弥补股息资金缺口 自2022年12月以来流通股数量增加70% 2021至2024年间通过增发股份覆盖3800万美元股息短缺[6] - 公司现金状况紧张 目前仅持有840万美元现金 但面临每季度1400万美元股息支出和570万美元经常性资本支出 另有约1200万美元计划资本支出[6] - 公司被指控使用虚假贷款隐瞒Ashford Lane主要租户倒闭情况 向股东隐藏了重要经营风险[6] 市场表现与事件影响 - 2025年6月25日Wolfpack发布做空报告后 公司股价单日下跌0.98美元 跌幅达5.42% 收盘报17.10美元[7] - Wolfpack报告将公司与B Riley进行不利比较 后者因三年亏损、投资失败、财报延迟及SEC调查等问题市值下跌超过90%[6] 法律诉讼进展 - 联邦证券集体诉讼已于2025年10月7日截止申请首席原告资格 指控公司及高管违反证券法 发布虚假和误导性陈述[3][5] - 诉讼指控公司业务和财务前景被夸大 管理层公开陈述在相关时间存在重大虚假和误导性[5]